Rachel House

Sep 30, 2024 | mdpi.com | Georgina Jones |Rachel House |Sinthia Bosnic-Anticevich |Lynn Cheong

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Aug 12, 2024 | academic.oup.com | Rachel House |Hui Shen |Carrie Graveel |James P. Eapen

Measuring cellular energetics is essential to understanding a matrix’s (e.g. cell, tissue or biofluid) metabolic state. The Agilent Seahorse machine is a common method to measure real-time cellular energetics, but existing analysis tools are highly manual or lack functionality. The Cellular Energetics Analysis Software (ceas) R package fills this analytical gap by providing modular and automated Seahorse data analysis and visualization.

Mar 28, 2024 | cgmagonline.com | Shakyl Lambert |Dan Stevens |Rachel House

There’s really just something about the spectacle of seeing giant monsters tear up cities that makes me feel like a kid again. Maybe I’m easier to please than most, but that might be why I’ve enjoyed all of the previous four MonsterVerse films to varying degrees. Godzilla vs. Kong was, in my estimation, the strongest to date, and thankfully, Godzilla x Kong: The New Empire manages to retain a lot of what made the last movie work.

Mar 28, 2024 | imdb.com | Rachel House |Tom Furniss

Explores the journey of three young people as they seek solace under the watchful gaze of the Taranaki mountain and companionship in the spirit of adventure.Explores the journey of three young people as they seek solace under the watchful gaze of the Taranaki mountain and companionship in the spirit of adventure.Explores the journey of three young people as they seek solace under the watchful gaze of the Taranaki mountain and companionship in the spirit of adventure.

Nov 25, 2023 | biorxiv.org | Rachel House |Elizabeth A Tovar |Curt J Essenburg |Patrick S. Dischinger

AbstractObjective: NF1 is a tumor suppressor gene and its protein product, neurofibromin, is the key negative regulator of the RAS pathway. NF1 is one of the top driver mutations in sporadic breast cancer such that 27% of breast cancers exhibit damaging NF1 alterations. NF1 loss–of–function is a frequent event in the genomic evolution of estrogen receptor (ER)+ breast cancer metastasis and endocrine resistance.